*A Private Investor is a recipient of the information who meets all of the conditions set out below, the recipient:
Obtains access to the information in a personal capacity;
Is not required to be regulated or supervised by a body concerned with the regulation or supervision of investment or financial services;
Is not currently registered or qualified as a professional securities trader or investment adviser with any national or state exchange, regulatory authority, professional association or recognised professional body;
Does not currently act in any capacity as an investment adviser, whether or not they have at some time been qualified to do so;
Uses the information solely in relation to the management of their personal funds and not as a trader to the public or for the investment of corporate funds;
Does not distribute, republish or otherwise provide any information or derived works to any third party in any manner or use or process information or derived works for any commercial purposes.
IDH is a leading consumer healthcare company in the Middle East and Africa with operations in Egypt, Jordan, Sudan and Nigeria and is proudly woman-led. A long track record for quality and safety has earned the Group a trusted reputation, as well as internationally-recognised accreditations for its portfolio of over 2,000 diagnostics tests. From its base of over 480 branches, the Company will continue to add laboratories through a Hub, Spoke and Spike business model that provides a scalable platform for efficient expansion.
Registrars:
Key Personnel
CFO:
Sherif El Zeiny , Ahmed El Gebeily
Non-Executive Director:
Richard Henry Phillips
Non-Executive Chairman:
Anthony St John
Group Chief Executive:
Hend El Sherbini
Independent Non-Executive Director:
Dan Olsson, Yvonne Stillhart, Hussein Choucri
Contact Details
Address:
12 Castle Street, Street St Helier, Jersey, United Kingdom